Name of Drug Classification Mechanism of Action Indication Contraindication Side Effects Nursing Responsibilities

DRUG
Patient’s Initials: _______________________________ Date of Admission: _______________________ Diagnosis: ________________________________

Age: ________________________________________ Height/Weight: __________________________ Clinical Intervention: ________________________
Sex:_________________________________________ Ward: _____ Bed No: _____ Name of Physician:_________________________
Nursing
Name of Drug Classification Mechanism of Action Indication Contraindication Side Effects
Responsibilities
Generic Name: Therapeutic Class: Chemical: General Indications:  Anaphylactic reaction  Arthralgia Before:
Pneumococcal Vaccine Pneumococcal vaccine, Active immunization after a previous dose  Chills 1. Assess the history
conjugate vaccine an inactive bacterial against pneumococcal or to vaccine  ↓ appetite and current health
Pharmacological Class: vaccine, contains disease component (including  Fatigue
condition of the
Trade Name: Antisera & purified capsular diphtheria toxoid).  Fever
13-valent, PCV13, Immunologicals polysaccharides of Patient’s indications:  Hypersensitivity  Headache
patient to
Prevnar 13 pneumococcal serotypes All infants aged from 6  Insomnia determine whether
Pregnancy Risk 1, 2, 3, 4, 5, 6B, 7F, 8, weeks up until 12 Precautions:  Irritability the vaccine is safe
Dosage: Category: 9N, 9V, 10A, 11A, 12F, months History of coagulation  Myalgia to be administered
1st (0.5 mL) dose at 6 Category C 14, 15B, 17F, 18C, 19F, disorders, severe CV  pain @ injection site or not
weeks 19A, 20, 22F, 23F, and and pulmonary  rash 2. Educate patients
2nd (0.5 mL) dose at 10 33F that promotes dysfunction, about the diseases
weeks active immunization immunosuppression. targeted by PCV
3rd (0.5 mL) dose at 14 against diseases caused Postpone vaccination in
vaccine, and the
weeks by these S. pneumoniae patients with moderate
serotypes. or severe acute febrile benefits, potential
Route of administration: illness. Not indicated risks and
Intramuscular (IM) Onset: Immunity: for treatment of contraindications
injection to the Approx. 2-3 weeks pneumococcal 3. Inform them of the
anterolateral aspect of infections. Renal and possible side
the thigh in infants Duration: at least 5 hepatic impairment. effects of the
years Children. Pregnancy vaccine, and as
and lactation. well as the
Drug Interactions:
possibility of
Increased risk of . experiencing pain
bleeding with and swelling at the
anticoagulants. injection site;
Decreased immune instruct them to
response with apply ice on the
immunosuppressive area to reduce
therapies (e.g. high dose swelling.
corticosteroids).
4. Keep vaccine
away from
sunlight, since
such exposure
may inactivate the
viruses.
During:
1. Identify patient
2. Assist client in the
administration of
vaccine
3. Inspect the
parenteral drug
product for
particulate matter
and discoloration
prior to
administration
After:
1. Observe for and
record the side
effects manifested
by the patient - If
the pt. is still on
the first shot,
remind him/her of
the date of his/her
second dose of
vaccine
2. Monitor for
anaphylaxis and
syncope for 15
minutes following
administration. If
seizure-like
activity associated
with syncope
occurs, maintain
patient in supine
or Trendelenburg
position to re-
establish adequate
cerebral perfusion.
3. Report severe
reactions
Source: Source: Source: Source: Source: Source: Source:
DOH Vaccine, Vaccine, Vallerand, A.H., Vallerand, A.H., Vallerand, A.H., Vallerand, A.H.,
pneumococcal: pneumococcal: Sanoski, C.A., & Sanoski, C.A., & Sanoski, C.A., & Sanoski, C.A., &
Vallerand, A.H., Indication, Dosage, Indication, Dosage, Deglin, J.H. (2017). Deglin, J.H. (2017). Deglin, J.H. (2017). Deglin, J.H. (2017).
Sanoski, C.A., & Side Effects, Side Effects, Davis’s Drug Guide for Davis’s Drug Guide for Davis’s Drug Guide for Davis’s Drug Guide for
Deglin, J.H. (2017). Precaution. (n.d.). Precaution. (n.d.). Nurses, 15th ed. Nurses, 15th ed. Nurses, 15th ed. Nurses, 15th ed.
Davis’s Drug Guide for Retrieved February 25, Retrieved February 25, Philadelphia: F.A. Philadelphia: F.A. Philadelphia: F.A. Philadelphia: F.A. Davis
Nurses, 15th ed. 2020, from MIMS: 2020, from MIMS: Davis Company. Davis Company. Davis Company. Company.
Philadelphia: F.A. https://www.mims.com/ https://www.mims.com/
Davis Company. philippines/drug/info/ philippines/drug/info/ Vaccine,
vaccine%2C%20p vaccine%2C%20p pneumococcal:
neumococcal/ neumococcal/ Indication, Dosage,
Side Effects,
Precaution. (n.d.).
Retrieved February 25,
2020, from MIMS:
https://www.mims.com/
philippines/drug/info/
vaccine%2C%20p
neumococcal/

Name of Drug Classification Mechanism of Action Indication Contraindication Side Effects Nursing Responsibilities

Uploaded by

Copyright:

Available Formats

Name of Drug Classification Mechanism of Action Indication Contraindication Side Effects Nursing Responsibilities

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Name of Drug Classification Mechanism of Action Indication Contraindication Side Effects Nursing Responsibilities

Uploaded by

Copyright:

Available Formats

DRUG

Patient’s Initials: ___________________ Date of Admission: _ Diagnosis: ______________________

You might also like